Get access

DYT6 in Japan—genetic screening and clinical characteristics of the patients

Authors

  • Ryosuke Miyamoto MD,

    Corresponding author
    1. Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan
    2. Department of Epidemiology, Research Institute for Radiation Biology & Medicine, Hiroshima University, Hiroshima, Japan
    3. The Movement Disorders Clinic, Ijinkai Takeda General Hospital, Kyoto, Japan
    • Correspondence to: Dr. Ryosuke Miyamoto, Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan 770-8503; ryom@tokushima-u.ac.jp

    Search for more papers by this author
  • Hidetaka Koizumi MD,

    1. Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan
    2. The Movement Disorders Clinic, Ijinkai Takeda General Hospital, Kyoto, Japan
    Search for more papers by this author
  • Hiroyuki Morino MD,

    1. Department of Epidemiology, Research Institute for Radiation Biology & Medicine, Hiroshima University, Hiroshima, Japan
    Search for more papers by this author
  • Toshitaka Kawarai MD,

    1. Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan
    Search for more papers by this author
  • Hirofumi Maruyama MD,

    1. Department of Epidemiology, Research Institute for Radiation Biology & Medicine, Hiroshima University, Hiroshima, Japan
    Search for more papers by this author
  • Yohei Mukai MD,

    1. The Movement Disorders Clinic, Ijinkai Takeda General Hospital, Kyoto, Japan
    2. Department of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for more papers by this author
  • Ai Miyashiro MD,

    1. Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan
    2. The Movement Disorders Clinic, Ijinkai Takeda General Hospital, Kyoto, Japan
    Search for more papers by this author
  • Wataru Sako MD,

    1. Department of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for more papers by this author
  • Yuishin Izumi MD,

    1. Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan
    Search for more papers by this author
  • Hideshi Kawakami MD,

    1. Department of Epidemiology, Research Institute for Radiation Biology & Medicine, Hiroshima University, Hiroshima, Japan
    Search for more papers by this author
  • Ryuji Kaji MD

    1. Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan
    2. The Movement Disorders Clinic, Ijinkai Takeda General Hospital, Kyoto, Japan
    Search for more papers by this author

  • Funding agencies: This work was supported by Grants-in-Aid from the Dystonia Research Committee, Ministry of Health, Labor, and Welfare of Japan (to R.K.); the Funding Program for Next-Generation, World-Leading Researchers from the Cabinet Office, Government of Japan; a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.Maruyama); and a Grant-in-Aid from the Research Committee of Central Nervous System Degenerative Diseases, the Ministry of Health, Labor, and Welfare of Japan (to H.Kawakami).

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary